Samuel Sherratt

1.3k total citations
51 papers, 928 citations indexed

About

Samuel Sherratt is a scholar working on Nutrition and Dietetics, Surgery and Biochemistry. According to data from OpenAlex, Samuel Sherratt has authored 51 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Nutrition and Dietetics, 21 papers in Surgery and 21 papers in Biochemistry. Recurrent topics in Samuel Sherratt's work include Fatty Acid Research and Health (27 papers), Eicosanoids and Hypertension Pharmacology (19 papers) and Cholesterol and Lipid Metabolism (11 papers). Samuel Sherratt is often cited by papers focused on Fatty Acid Research and Health (27 papers), Eicosanoids and Hypertension Pharmacology (19 papers) and Cholesterol and Lipid Metabolism (11 papers). Samuel Sherratt collaborates with scholars based in United States, France and India. Samuel Sherratt's co-authors include R. Preston Mason, Robert F. Jacob, Deepak L. Bhatt, Ronald P. Mason, Peter Libby, Amitabha Chattopadhyay, S. K. Shrivastava, Tadeusz Maliñski, Rebecca A. Juliano and Eleanor M. Riley and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Stroke.

In The Last Decade

Samuel Sherratt

46 papers receiving 903 citations

Peers

Samuel Sherratt

SURGE

BIOCH

EDM

M. Cehun Australia

Fernando Lopez‐Segura Spain

Hans Fagertun Norway

Nalini Kaul United States

E.A.M. de Deckere Netherlands

Juan Antonio Pacheco Paniagua Spain

Paloma Benito United States

Mihir Parikh Canada

Susan M Jalbert United States

Rosanna W. S. Chung Australia

M. Cehun Australia

Samuel Sherratt

459 ×0.9

335 ×1.1

SURGE

125 ×0.4

BIOCH

158 ×1.0

192 ×1.2

EDM

Citations per year, relative to Samuel Sherratt Samuel Sherratt (= 1×) peers M. Cehun

Countries citing papers authored by Samuel Sherratt

Since Specialization

Citations

This map shows the geographic impact of Samuel Sherratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Sherratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Sherratt more than expected).

Fields of papers citing papers by Samuel Sherratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Sherratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Sherratt. The network helps show where Samuel Sherratt may publish in the future.

Co-authorship network of co-authors of Samuel Sherratt

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Sherratt. A scholar is included among the top collaborators of Samuel Sherratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Sherratt. Samuel Sherratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sherratt, Samuel, R. Preston Mason, Peter Libby, & Deepak L. Bhatt. (2024). “A Time to Tear Down and a Time to Mend”: The Role of Eicosanoids in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 44(11). 2258–2263. 4 indexed citations

Sherratt, Samuel, et al.. (2024). Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation. Journal of the American Heart Association. 13(14). e034076–e034076. 11 indexed citations

Sherratt, Samuel. (2023). REDUCE-IT, biomarkers, and confirmation bias: are we missing the forest for the trees?. European Journal of Preventive Cardiology. 31(15). e113–e114. 2 indexed citations

Sherratt, Samuel, R. Preston Mason, Peter Libby, Philippe Gabríel Steg, & Deepak L. Bhatt. (2023). Do patients benefit from omega-3 fatty acids?. Cardiovascular Research. 119(18). 2884–2901. 35 indexed citations

Sherratt, Samuel, et al.. (2023). Abstract 16934: Eicosapentaenoic Acid Inhibits Lipoprotein(a) With Higher Rates of Oxidation Compared to Non-Modified Low-Density Lipoprotein in vitro. Circulation. 148(Suppl_1). 1 indexed citations

Sherratt, Samuel, Peter Libby, Matthew J. Budoff, Deepak L. Bhatt, & R. Preston Mason. (2022). Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current Atherosclerosis Reports. 25(1). 1–17. 70 indexed citations

Sherratt, Samuel, et al.. (2022). EICOSAPENTAENOIC ACID (EPA) REDUCES INFLAMMATION AND IMPROVES NITRIC OXIDE BIOAVAILABILITY IN PULMONARY ENDOTHELIAL CELLS FOLLOWING EXPOSURE TO AIR POLLUTION PARTICLES. Journal of the American College of Cardiology. 79(9). 1758–1758. 1 indexed citations

Mason, R. Preston, Samuel Sherratt, & Robert H. Eckel. (2022). Omega-3-fatty acids: Do they prevent cardiovascular disease?. Best Practice & Research Clinical Endocrinology & Metabolism. 37(3). 101681–101681. 21 indexed citations

Sherratt, Samuel, et al.. (2021). EPA and DHA containing phospholipids have contrasting effects on membrane structure. Journal of Lipid Research. 62. 100106–100106. 50 indexed citations

10.

Mason, R. Preston, et al.. (2021). EICOSAPENTAENOIC ACID (EPA) INCREASES HEME OXYGENASE-1 EXPRESSION IN ENDOTHELIAL CELLS UNDER CONDITIONS OF INFLAMMATION UNLIKE DOCOSAHEXAENOIC ACID (DHA). Journal of the American College of Cardiology. 77(18). 1829–1829. 2 indexed citations

11.

Mason, R. Preston, et al.. (2021). PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1 (PECAM-1) AND NITROXIDATIVE STRESS REDUCED BY EICOSAPENTAENOIC ACID (EPA) DURING CYTOKINE EXPOSURE IN ENDOTHELIAL CELLS. Journal of the American College of Cardiology. 77(18). 1831–1831. 1 indexed citations

12.

Il’Giovine, Zachary J., James B. Williams, Ronald P. Mason, et al.. (2021). Kinetics of generic tacrolimus in heart transplantation: A cautionary note. The Journal of Heart and Lung Transplantation. 40(7). 569–572. 4 indexed citations

13.

Mason, Ronald P. & Samuel Sherratt. (2020). EICOSAPENTAENOIC ACID INHIBITS OXIDATION OF VERY LARGE DENSITY LIPOPROTEINS (VLDL) IN A DOSE-DEPENDENT MANNER OVER TIME AS COMPARED TO DOCOSAHEXAENOIC ACID IN VITRO. Journal of the American College of Cardiology. 75(11). 2238–2238. 1 indexed citations

14.

Sherratt, Samuel, Rebecca A. Juliano, & R. Preston Mason. (2020). Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(7). 183254–183254. 47 indexed citations

15.

Mason, R. Preston, et al.. (2019). Progressive LDL Reduction to Very Low Levels Improves Dimeric Nitric Oxide Synthase, Nitric Oxide Bioavailability and Reduces Peroxynitrite in Endothelial Cells during Hyperglycemia. American Journal of Pharmacology and Toxicology. 14(1). 7–16. 5 indexed citations

16.

Sherratt, Samuel, Pierre Villeneuve, Erwann Durand, & Ronald P. Mason. (2018). Rosmarinic acid and its esters inhibit membrane cholesterol domain formation through an antioxidant mechanism based, in nonlinear fashion, on alkyl chain length. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1861(3). 550–555. 10 indexed citations

17.

Sherratt, Samuel & R. Preston Mason. (2018). Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction. Chemistry and Physics of Lipids. 212. 73–79. 75 indexed citations

18.

Mason, R. Preston, et al.. (2016). EICOSAPENTAENOIC ACID AND ATORVASTATIN ACTIVE METABOLITE, ALONE OR IN COMBINATION, REVERSED GLUCOSE- AND OXIDIZED LDL-INDUCED ENDOTHELIAL DYSFUNCTION MEASURED EX VIVO IN RATS. Journal of the American College of Cardiology. 67(13). 2320–2320. 3 indexed citations

19.

Mason, Ronald P. & Samuel Sherratt. (2016). Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits. Biochemical and Biophysical Research Communications. 483(1). 425–429. 84 indexed citations

20.

Sherratt, Samuel, S. K. Shrivastava, Robert F. Jacob, Amitabha Chattopadhyay, & Ronald P. Mason. (2016). Docosahexaenoic Acid (DHA), but not Eicosapentaenoic Acid (EPA), Increases Both Membrane Fluidity and Cholesterol Crystalline Domain Formation in Lipid Vesicles. Biophysical Journal. 110(3). 583a–583a. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact